American Journal of Health-System Pharmacy

American Journal of Health-System Pharmacy is the official journal of the American Society of Health-System Pharmacists, issued twice a month under an Oxford University Press imprint and read mainly by hospital pharmacists.《美国卫生系统药学杂志》是美国卫生系统药师学会（ASHP）的官方刊物，由 Oxford University Press 以半月刊形式出版，读者以医院与卫生系统中的药师为主。

Its pages take up drug therapy as it is actually delivered, from formulary decisions and sterile compounding to stewardship rounds, so the audience is the pharmacy department rather than the laboratory.刊物讨论药物疗法在真实机构中的落地，内容覆盖处方集决策、无菌配制与抗菌药物管理查房，服务对象是药学部门而非实验室。

A 2025 Journal Impact Factor of 1.9 and a five-year figure of 2.4 put it 253rd of 356 titles in the Clarivate pharmacology and pharmacy category, a third-quartile placing that leaves it below the median for the field.2025 年影响因子 1.9，五年影响因子 2.4，在 Clarivate 的药理学与药学类目 356 种期刊中排第 253 位，落在第三四分位。

Scope

• Pharmacy and therapeutics committee work sits at the centre, with formulary reviews, drug class evaluations and drug-use policy written for institutions that must defend every addition to the list.药事与治疗委员会的工作居于中心，处方集评审与药物类别评估常在此展开，用药政策面向必须为每一款新药给出理由的机构。
• Clinical pharmacy services get steady coverage, from pharmacist rounds in intensive care and emergency departments to anticoagulation clinics, transitions of care and the staffing levels that make them possible.临床药学服务长期在版面之内，重症监护与急诊科的药师查房、抗凝门诊、转科衔接都在此列，支撑这些服务的人员配置同样被讨论。
• Medication safety forms a standing subject, covering error reporting systems, high-alert drugs, look-alike packaging, smart pump libraries and the root-cause work that follows a harmful event.用药安全是常设主题，差错上报系统、高危药品与形似包装都在其内，伤害事件之后的根因分析也一并刊出。
• Sterile compounding and hazardous drug handling carry weight, with cleanroom design, environmental monitoring, beyond-use dating and the practical reading of United States Pharmacopeia chapters 797 and 800.无菌配制与危害药品处理分量不轻，洁净室设计、环境监测与效期外使用期限都在其中，美国药典第 797 章与第 800 章的实务解读也曾刊出。
• Antimicrobial stewardship receives frequent attention, and restriction policies, de-escalation, rapid diagnostics and outpatient parenteral therapy are examined alongside the prescribing data used to judge them.抗菌药物管理受到频繁关注，限制性用药政策与降阶梯治疗常见，快速诊断和门诊肠外治疗同样被讨论，评判效果的处方数据一并呈现。
• Informatics runs through the journal, with computerised order entry, barcode medication administration, automated dispensing cabinets, telepharmacy and the early uses of machine learning in dispensing workflows.信息学贯穿全刊，计算机化医嘱录入与条码给药是常见题目，自动发药机、远程药学的实践报告也在其中，机器学习在发药流程里的早期尝试已经出现。
• Management and workforce questions appear regularly, from staffing ratios and technician advancement to burnout, business planning, the cost of new services and the pharmacy's place in hospital budget negotiations.管理与人力议题定期出现，人员配比与技术员职级晋升受到关注，职业倦怠、业务规划与新服务成本也在其中，药学部在预算谈判中的位置同样被讨论。
• Health economics and outcomes research finds room, with cost-effectiveness models, budget impact estimates and readmission analyses aimed at committees that must justify spending to administrators.卫生经济学与结局研究占有位置，成本效果模型与预算影响测算常见，再入院分析面向需要向管理层解释支出的委员会。
• Emergency and critical care practice, paediatrics and oncology all keep a foothold, and dosing in organ dysfunction, resuscitation drugs and chemotherapy preparation recur across volumes.急诊与危重症实践、儿科与肿瘤药学各有位置，器官功能不全时的给药、复苏用药与化疗配制在历年卷册中反复出现。
• Case reports and clinical consultations give practitioners a place to publish single-patient experience and literature-based answers to questions that arrive at the dispensing window, including ones that no published guideline settles.病例报告与药学问答为一线从业者留出位置，既可发表单例经验，也可就窗口前遇到、指南未及的疑问给出基于文献的回答。
• Formal documents from the society belong to the remit, so ASHP guidelines, practice standards and policy statements reach print in the same pages as research reports.学会的正式文件属于刊物职责，ASHP 指南与实践标准常与政策声明一并刊出，与研究论文共享同一份刊物。
• Vaccine administration, public health emergencies and drug shortages have drawn attention in recent years, subjects that follow the profession into clinics and community settings beyond the ward.疫苗接种与突发公共卫生事件近年进入视野，药品短缺的应对报告也在其中，这些题目把药学实践带出病房，延伸到门诊与社区。
• Education and residency training get space too, from experiential teaching models to the standards that govern postgraduate year one and year two programmes in the United States.教育与住院药师培训同样有版面，从体验式教学模式，到规范美国第一年与第二年住院药师培训的标准，都有涉及。
• An international readership is acknowledged, and articles on pharmacy practice in low-resource settings sit beside American policy analysis, an editorial choice that widens the comparison base.国际读者得到承认，资源有限地区的药学实践与美国的政策分析并列刊出，这种编排拓宽了比较的基础。

History

• Volume 52, number 1, dated 1 January 1995, carried the present title for the first time, and the National Library of Medicine starts its MEDLINE record at that issue.1995 年 1 月 1 日出版的第 52 卷第 1 期首次使用现名，美国国家医学图书馆的 MEDLINE 记录也从这一期起算。
• Volume numbering did not restart, however, and Crossref deposits under the current ISSN reach back to 1943, when volume 1 appeared as the society's bulletin under a different name.卷号并未从头开始，当前 ISSN 下的 Crossref 存档可回溯到 1943 年，第 1 卷即以学会公报的形式问世。
• Volume 15 opened in 1958, the year the title took the name American Journal of Hospital Pharmacy, and volumes ran on without a break until the 1995 change.第 15 卷于 1958 年开始，刊名在这一年改为 American Journal of Hospital Pharmacy，此后卷号连续未断，直至 1995 年启用现名。
• From the 1995 relaunch until the Oxford move, the society published the title itself from Bethesda, Maryland, the imprint the library catalogue still records for those volumes.1995 年改版之后到移交牛津之前，刊物由学会在贝塞斯达自办出版，图书馆目录至今把这些卷的出版地记作该城。
• Oxford University Press took over publication in 2019, and the current imprint names the press and the city of Oxford, while ownership of the title stayed with the society.2019 年 Oxford University Press 接手出版，现行出版项同时记下出版社名与牛津，刊物的所有权仍留在学会。
• Semimonthly publication has held through the recent period, twenty-four numbered issues to a volume, and one volume covers a calendar year, so 2025 closed as volume 82.半月刊的形制在近些年保持不变，每卷 24 个编号期，一卷对应当年，2025 年出到第 82 卷。
• Supplements travel with the volume, and recent years have carried up to six of them, mostly meeting abstracts and themed collections printed outside the regular numbering.增刊随卷发行，近年一卷最多见到六期，多为会议摘要与专题文集，编号独立于常规期号。
• Crossref holds more than 31,900 records under the two ISSNs, and the older ones arrived as a digitised back file rather than being registered at the time of publication.两个 ISSN 之下 Crossref 收录逾 31900 条记录，较早的一批以数字化回溯方式提交，出版当年并未逐条登记。
• Impact factors moved from 2.637 in 2021 to 2.98 in 2022, fell to 2.1 and then 2.3 in the following two releases, and settled at 1.9 in the 2025 release.影响因子 2021 年为 2.637，2022 年升至 2.98，随后两次公布落到 2.1 与 2.3，2025 年为 1.9。
• Citation counts stand at 6,487 with a cited half-life of 7.9 years, a profile that fits a practice journal whose back volumes stay in use by working pharmacists.总被引 6487 次，被引半衰期 7.9 年，这种形态与一份实践类刊物相符，旧卷仍被在职药师翻检。
• Output runs near 172 articles a year in the 2025 release, and a Journal Citation Indicator of 0.44 sits below the category norm, consistent with a national practice title.2025 年榜显示年发文约 172 篇，期刊引文指标 0.44 低于类目均值，这与一份以本国实践为主的刊物相称。
• Gold open access accounts for 7.71 percent of papers, so the model is hybrid, and most articles still reach readers through institutional subscriptions bought by hospitals and colleges.金色开放获取占论文的 7.71%，模式为混合型，多数文章仍经由医院与药学院购买的机构订阅到达读者。
• A percentile standing of 29.1 keeps the title in the lower third of its category, a position it has held through several years of falling and recovering scores.百分位 29.1 把它放在类目的下三分之一，这一位置在分数起落数年之间大体未变。

Editors

• An editor-in-chief heads the masthead and works with associate editors and a salaried editorial office, a structure the society keeps for its flagship publication.主编领衔编委会，与副编辑及受薪编辑部共事，学会为其旗舰刊物保留了这一架构。
• Board members come mostly from academic medical centres and colleges of pharmacy, with hospital pharmacy directors, clinical specialists and a few health-system executives among them.编委多来自学术医疗中心与药学院，其中既有医院药学主任与临床专科药师，也有卫生系统管理层人士。
• Every research report is refereed outside the office, and referees are chosen for practice experience as much as for publication record, which shapes the comments authors receive.每篇研究报告都在编辑部之外送审，审稿人的挑选兼顾实践经验与发表记录，作者收到的意见因此带有实务取向。
• Article types are fixed by function, and the journal separates original research, notes, case reports, clinical consultations, commentaries, letters and review articles, each with its own length limit and review path.文章类型按功能划分，原创研究与研究简报各自成类，病例报告与药学问答另有通道，评论、读者来信与综述同样分开处理，篇幅与评审路径各不相同。
• The clinical consultation format pairs a practitioner's question with a structured literature appraisal, and it remains one of the ways the journal answers problems raised at the point of care.药学问答栏目把一线提问与结构化的文献评析配在一起，它至今仍是刊物回应诊疗现场疑问的一条通道。
• Case reports are kept short and are judged on teaching value, so a familiar presentation with an unusual twist stands a better chance than a rare disease reported at length.病例报告篇幅压得很短，取舍看教学价值，常见病症里的异常转折比长篇记录罕见病更容易入选。
• Guidelines and practice standards follow a separate track, drafted by the society's councils and sections, debated in its policy bodies and printed once the board has approved them.指南与实践标准走另一条路径，由学会的理事会与各分会起草，在政策机构中辩论，经董事会批准后刊出。
• Supplements carry meeting abstracts and sponsored symposia, and the editorial office marks commercial support so that a reader can tell a sponsored collection from the peer-reviewed pages.增刊承载会议摘要与赞助专题，编辑部会标明商业支持，读者因此能分辨赞助文集与经过同行评议的正文。
• Disclosure of financial relationships is required of authors, and the journal prints funding statements beside the articles instead of gathering them in a separate section.作者须披露经济利益关系，资助声明与正文并排印出，未集中存放于另设章节。
• Correspondence is handled through a letters column, and corrections appear with a link back to the paper they amend so the record stays traceable for anyone who cites it.读者来信设有专门栏目，更正启事附回原论文的指向，引用者仍能追到记录的原貌。
• Copy editing follows the journal's own style, structured abstracts are required for research, and tables are trimmed so that a busy practitioner can read an article between cases.文字编辑依刊物自家体例，研究论文须附结构式摘要，表格经过压缩，忙碌的药师能在两例病人之间读完一篇。
• The editorial office applies a practice test to submissions, asking whether a paper would change what a pharmacy department does in the following week rather than what it might cite.编辑部对稿件先过一道实践检验，追问一篇论文能否改变药学部门下一周的做法。